StockData
GENELUX Corp logo

GENELUX Corp (GNLX) stock

GNLXNasdaqPharmaceutical PreparationsFiscal year ends December 31
Financials through Q2 FY2026, quarter ended Jun 30, 2026Last filing: 10-Q on Aug 13, 2026Score 5/30
$2.00+0.08 (+4.17%)

Close on Nov 17, 2026Market cap $90.49MP/E –Yield –

Genelux total debt

Total debt is short-term plus long-term borrowings on the balance sheet at the end of each period.

Genelux's total debt was $900.00K at Dec 31, 2023. For fiscal 2023 it was $900.00K.

Annual total debt

PeriodPeriod endValueChange
FY2023Dec 31, 2023$900.00K–

Quarterly total debt

Change is against the same quarter a year earlier.

PeriodPeriod endValueChange
Q4 FY2023Dec 31, 2023$900.00K–
Q3 FY2023Sep 30, 2023$900.00K–
Q2 FY2023Jun 30, 2023$900.00K–
Q1 FY2023Mar 31, 2023$900.00K–

More Genelux figures

See a number that looks wrong?